Apelin-13 exerts antidepressant-like and recognition memory improving activities in stressed rats

Eur Neuropsychopharmacol. 2016 Mar;26(3):420-30. doi: 10.1016/j.euroneuro.2016.01.007. Epub 2016 Jan 28.

Abstract

Apelin is the endogenous ligand for the G-protein-coupled receptor (APJ). The localization of APJ in limbic structures suggests a potential role for apelin in emotional processes. However, the role of apelin in the regulation of stress-induced responses such as depression and memory impairment is largely unknown. In the present study, we evaluated the role of apelin-13 in the regulation of stress-induced depression and memory impairment in rats. We report that repeated intracerebroventricular injections of apelin-13 reversed behavioral despair (immobility) in the forced swim (FS) test, a model widely used for the selection of new antidepressant agents. Apelin-13 also reversed behavioral deficits (escape failure) in the learned helplessness test. The magnitude of the antiimmobility and anti-escape failure effects of apelin-13 was comparable to that of imipramine, a classic antidepressant used as a positive control. Rats exposed to FS stress showed memory performance impairment in the novel object recognition test, and this impairment was improved by apelin-13 treatment. Apelin-13 did not affect recognition memory performance in non-stressed rats. Furthermore, the pretreatment of LY294002 (PI3K inhibitors) or PD98059 (ERK1/2 inhibitor) blocked apelin-13-mediated activities in FS-stressed rats. These findings suggest that apelin-13 exerts antidepressant-like and recognition memory improving activities through activating PI3K and ERK1/2 signaling pathways in stressed rats.

Keywords: Antidepressant; Apelin; ERK; Memory; PI3K; Stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antidepressive Agents / pharmacology
  • Antidepressive Agents / therapeutic use
  • Chromones / pharmacology
  • Chromones / therapeutic use
  • Corticosterone / blood
  • Depression / drug therapy*
  • Depression / etiology
  • Disease Models, Animal
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Flavonoids / pharmacology
  • Flavonoids / therapeutic use
  • Helplessness, Learned
  • Injections, Intraventricular
  • Intercellular Signaling Peptides and Proteins / pharmacology*
  • Intercellular Signaling Peptides and Proteins / therapeutic use*
  • Locomotion / drug effects
  • Male
  • Memory Disorders / drug therapy*
  • Memory Disorders / etiology
  • Morpholines / pharmacology
  • Morpholines / therapeutic use
  • Rats
  • Rats, Wistar
  • Recognition, Psychology / drug effects*
  • Stress, Psychological / blood
  • Stress, Psychological / complications
  • Swimming / psychology
  • Time Factors

Substances

  • Antidepressive Agents
  • Chromones
  • Enzyme Inhibitors
  • Flavonoids
  • Intercellular Signaling Peptides and Proteins
  • Morpholines
  • apelin 13, Pyr(1)-
  • 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
  • 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one
  • Corticosterone